Explore the Organ-On-Chip market (2026–2031) with Mordor Intelligence™. Get in-depth insights on market size, share, revenue, segments, key drivers, latest trends, and growth opportunities shaping the future of sustainable construction.
Organ-On-Chip Market Introduction and Outlook
The Organ-On-Chip market is witnessing steady expansion as pharmaceutical companies, research institutes, and regulators increase reliance on microphysiological systems for human-relevant testing. The Organ-On-Chip market size is expected to grow from USD 390 million in 2025 to USD 510 million in 2026 and is forecast to reach USD 1.85 billion by 2031, reflecting strong Organ-On-Chip market growth over the forecast period. This reflects rising acceptance of alternatives to animal testing and greater adoption in drug development workflows.
The Organ-On-Chip industry is being shaped by demand for more predictive preclinical models, particularly in drug safety testing and disease modeling. As Organ-On-Chip market forecast outlook strengthens, adoption is increasing across pharmaceutical pipelines, academic research, and clinical translation studies. The Organ-On-Chip market trends highlight a shift toward integrated testing platforms that combine biology, engineering, and data analysis to improve research outcomes.
Organ-On-Chip Market Trends and Growth Drivers
Regulatory acceptance supporting Organ-On-Chip market growth
A major driver of Organ-On-Chip market growth is regulatory movement toward reducing reliance on animal testing. Agencies such as the FDA are increasingly recognizing microphysiological systems as valid tools for safety and efficacy evaluation. This has encouraged pharmaceutical companies to integrate chip-based systems into early-stage drug screening workflows. As guidelines continue to evolve, the Organ-On-Chip market share of validated testing platforms is expected to expand further.
Expansion of drug discovery applications
Drug discovery remains a core application area for the Organ-On-Chip market. Pharmaceutical companies are using these systems to evaluate toxicity, metabolism, and absorption more accurately than traditional models. This helps reduce late-stage drug failures and improves pipeline efficiency. As a result, Organ-On-Chip market trends show strong adoption in preclinical testing environments where predictive accuracy is essential.
Increasing focus on disease modeling
The Organ-On-Chip industry is benefiting from growing interest in disease modeling, especially for complex conditions such as liver disorders, neurodegeneration, and inflammatory diseases. These systems replicate human tissue behavior under controlled conditions, enabling researchers to study disease progression in a more realistic environment. This supports more targeted drug development strategies and strengthens Organ-On-Chip market forecast potential.
For a more tailored understanding, view the localized Japanese edition alongside the global market breakdown – https://www.mordorintelligence.com/ja/industry-reports/organs-on-chips-market?utm_source=emailwire
Organ-On-Chip Market Segmentation Overview
By Organ Type
- Liver-on-chip systems
- Heart-on-chip systems
- Lung-on-chip systems
- Kidney-on-chip systems
- Other multi-organ systems
By Application
- Drug discovery and lead identification
- Toxicology testing
- Disease modeling
- ADME studies
- Precision medicine applications
By End User
- Pharmaceutical and biotechnology companies
- Academic and research institutes
- Contract research organizations
- Cosmetic and chemical testing industries
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Explore Our Full Library of Healthcare Research Reports – https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=emailwire
Organ-On-Chip Market Key Players
- Emulate Inc.
- CN Bio Innovations
- MIMETAS
- Altis Biosystems
- AxoSim
- BiomimX SRL
- Elveflow
- TissUse GmbH
- Nortis Inc.
- Draper Laboratory
Explore more insights on Organ-On-Chip competitive landscape: https://www.mordorintelligence.com/industry-reports/organs-on-chips-market/companies?utm_source=emailwire
Conclusion
The Organ-On-Chip market is expected to continue expanding as demand grows for more accurate and human-relevant testing systems. Strong Organ-On-Chip market growth is supported by regulatory acceptance, increasing pharmaceutical R&D investment, and rising demand for personalized medicine solutions.
Overall, the Organ-On-Chip market size is expected to grow significantly, with expanding Organ-On-Chip market share across pharmaceutical, biotechnology, and research sectors. The Organ-On-Chip industry is positioned for sustained adoption as innovation, regulatory support, and scientific demand continue to align over the forecast period.
Get the latest industry insights on Organ-On-Chip market growth: https://www.mordorintelligence.com/industry-reports/organs-on-chips-market?utm_source=emailwire
Industry Related Reports
AI in Precision Medicine Market
The AI in Precision Medicine market is expanding as healthcare systems adopt data-driven tools for personalized treatment planning and improved clinical outcomes. Growth is supported by increasing use of AI for genomic analysis, predictive diagnostics, and patient-specific therapy selection, with the market projected to grow from USD 7.75 billion in 2026 to USD 18.84 billion by 2031 at a 19.46% CAGR.
Bioprocess Technology Market
The Bioprocess Technology market is witnessing steady growth driven by rising demand for biologics, vaccines, and advanced therapeutics. Expansion in biopharmaceutical manufacturing capacity and continuous process optimization are key contributors, with the market expected to increase from USD 43.95 billion in 2026 to USD 85.73 billion by 2031 at a 14.3% CAGR.
Clinical EHR Market
The Clinical EHR market is growing steadily as healthcare providers increasingly adopt digital record systems to improve patient data management and care coordination. Rising focus on interoperability, regulatory compliance, and cloud-based healthcare infrastructure supports growth, with the market projected to rise from USD 23.34 billion in 2026 to USD 30.33 billion by 2031 at a 5.38% CAGR.
https://www.mordorintelligence.com/industry-reports/clinical-ehr-market?utm_source=emailwire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/